vTv Therapeutics
VTVT
VTVT
39 hedge funds and large institutions have $18M invested in vTv Therapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-2
Holders Change %
-4.88%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
13
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$506K |
| 2 |
SG Americas Securities
New York
|
+$64K |
| 3 |
Millennium Management
New York
|
+$61K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$56.3K |
| 5 |
Renaissance Technologies
New York
|
+$50.1K |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$267K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$216K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$172K |
| 4 |
BlackRock
New York
|
-$37.6K |
| 5 |
JPMorgan Chase & Co
New York
|
-$35K |
